DIVINANT, INC. – Trademark Portfolio

Entity Type: 03

DIVINANT, INC. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 4 trademarks are registered and 2 are pending. Notable registered marks include MIRTOUCH, BLUE BLISS, TICKLEFLEX, and TRAVEL SHARPS. The owner is based in Atascadero, CA.

PO BOX 70

Atascadero, CA 93423

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

DIVINANT, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does DIVINANT, INC. have?

DIVINANT, INC. has 7 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 pending, 1 abandoned.

What trademark classes does DIVINANT, INC. file in?

DIVINANT, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are DIVINANT, INC.'s most well-known trademarks?

DIVINANT, INC.'s registered trademark portfolio includes well-known marks such as MIRTOUCH, BLUE BLISS, TICKLEFLEX, and TRAVEL SHARPS. These are among 4 currently registered trademarks in the portfolio.

What is DIVINANT, INC.'s trademark registration success rate?

DIVINANT, INC. has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 2 applications are pending review.